Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 24, 2021

SELL
$9.01 - $12.01 $20,272 - $27,022
-2,250 Closed
0 $0
Q2 2021

Jul 30, 2021

SELL
$10.17 - $12.64 $7,627 - $9,480
-750 Reduced 25.0%
2,250 $27,000
Q1 2021

Apr 29, 2021

BUY
$10.88 - $17.05 $32,640 - $51,150
3,000 New
3,000 $38,000
Q3 2020

Oct 21, 2020

SELL
$9.38 - $12.48 $46,900 - $62,400
-5,000 Closed
0 $0
Q4 2019

Jan 22, 2020

BUY
$8.03 - $11.7 $40,150 - $58,500
5,000 New
5,000 $42,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.